More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline...(e exposure to iron. Common s...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008
e exposure to iron.
Common side effects of Gleevec tablets
The majority of adult Ph+ CML patients who received Gleevec in clinical studies experienced adverse reactions at some time, but most were mild to moderate in severity. The most frequently reported adverse reactions (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting (23%-58%), diarrhea (43%-57%), musculoskeletal pain (38%-49%) and rash and related terms (36%-47%)*(A).
Supportive care may help management of some mild-to-moderate adverse reactions so that the prescribed dose can be maintained whenever possible. However, in some cases, either a dose reduction or interruption of treatment with Gleevec may be necessary.
Gleevec tablets should be taken with food and a large glass of water to minimize GI irritation. Gleevec tablets should not be taken with grapefruit juice and other foods known to inhibit CYP3A4.
Patients should be informed to take Gleevec exactly as prescribed, not to change their dose or stop taking Gleevec unless they are told to do so by their doctor. If patients miss a dose, they should be advised to take their dose as soon as possible unless it is almost time for their next dose, in which case the missed dose should not be taken. A double dose should not be taken to make up for any missed dose.
*Numbers indicate the range of percentages in 4 studies among adult patients, with newly diagnosed Ph+ CML, patients in blast crisis, accelerated phase and in the chronic phase after failure of interferon-alpha therapy.
(A) For more detailed study information please see full Prescribing Information.
About Tasigna
Tasigna(R) (nilotinib) capsules are indicated for the treatment of chronic phase and accelerated phase Philadelphia chromosome-positive (Ph+) chronic mye
'/>"/>
| SOURCE Novartis Pharmaceuticals Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces that ... in its catalogue: ,, Boehringer Ingelheim ... ,, Introduction ,, This ... for Boehringer Ingelheim in the Rx pharmaceutical ... and pipeline analysis and assessment of financial ...
(Date:12/15/2009)... Dec. 15 ... announced that SDMS Vision Publisher(TM) (v.7.1 SR4), an ... Data Management System (SDMS), a secure electronic repository ... data to a centralized database and is used ... been certified compliant with the SAFE-BioPharma digital identity ...
(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The Future ... to 2015, Competitive Benchmarking, Product Pipeline ... http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, Summary ... latest research "The Future of HIV ...
Breaking Medicine Technology:Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Drug Candidates in Pipeline Offer Potential for Parkinsons Disease Therapeutics Market Says Frost 26amp 3B Sullivan 6851 1Drug Candidates in Pipeline Offer Potential for Parkinsons Disease Therapeutics Market Says Frost 26amp 3B Sullivan 6851 2Drug Candidates in Pipeline Offer Potential for Parkinsons Disease Therapeutics Market Says Frost 26amp 3B Sullivan 6851 3Ceridian Web Forum to Prepare Employers for Health Care Reform 62924 1Ceridian Web Forum to Prepare Employers for Health Care Reform 62924 2Ceridian Web Forum to Prepare Employers for Health Care Reform 62924 3Educus com Launches ICD 9 app for Apple iPhone and Android Devices 62922 1Educus com Launches ICD 9 app for Apple iPhone and Android Devices 62922 2Educus com Launches ICD 9 app for Apple iPhone and Android Devices 62922 3[0] Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile[0] Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard[0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
... - Study results show,that elevated lipoprotein-associated phospholipase ... plaque that can lead to heart attack ... risk in patients with the,metabolic syndrome--a serious ... The results, which were presented yesterday,at the ...
... /PRNewswire/ -- Cleveland Clinic,researchers today report that the ... or the "good",cholesterol by more than 60%, did ... coronary arteries as measured using an,ultrasound probe. , ... Clinic and lead investigator of this clinical trial, ...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 2Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 4(Date:12/15/2009)... help, experts say , , TUESDAY, Dec. 15 (HealthDay News) ... how to spot the signs of stroke in relatives ... , Emergency medical treatment within three hours of the ... damage and lead to better recovery. , The Kids ... graders in Texas who were divided into two groups. ...
(Date:12/15/2009)... that phthalates actually cause the condition, experts ... Common chemicals found in plastic toys and elsewhere ... in boys, preliminary research suggests. , The ... pediatricians, adds fuel to the debate over these ... by some scientists. The chemical industry claims the ...
(Date:12/15/2009)... of secure USB devices, today launches SafeConsole 4.0, the web ... software is designed to provide better usability for employees and ... and range of licensing options. , ... ... www.blockmastersecurity.com ) a leading provider of secure USB devices, today ...
(Date:12/15/2009)... within a week of getting news, researchers say ... stress can put newly diagnosed prostate cancer patients ... a new study has found. , Researchers analyzed ... cancer between 1961 and 2004. Of those men, ... a year of cancer diagnosis and 136 (0.08 ...
(Date:12/15/2009)... proud to announce the addition of David Tokofsky to ... Director of Development in the State of California and ... ,, David Tokofsky was elected to the Los ... 1995. As the Board Member for District Five, he ... Los Angeles through East Los Angeles to the Southeast ...
Breaking Medicine News(10 mins):Health News:Boosting Kids' Stroke IQ May Save Lives 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2[0] Boosting Kids' Stroke IQ May Save Lives[0] Breast Growth in Boys Might Be Linked to Plastics Chemical[0] BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices [0] Stress From Prostate Cancer Diagnosis May Be Fatal[0] Accelify Announces the Addition of David Tokofsky to its National Board of Advisors
... Effort is Launched With UC Davis Collaboration, ... KOOL ), a leading supplier of innovative ... cells for treatment of disease,and injury, today announced ... The Company has created a wholly-owned subsidiary, Vantus, ...
... toward personalized medicine, experts say , , WEDNESDAY, Feb. 6 (HealthDay ... could help a small minority of HIV patients discover whether ... cause serious side effects. , The test detects sensitivity to ... genetic makeup is linked to poor reactions to the medicine. ...
... risk factors at once, , , WEDNESDAY, Feb. 6 (HealthDay News) ... signs of some kidney damage may be able to significantly ... at once. , That,s the conclusion of a new ... New England Journal of Medicine , that found intensive ...
... Burnham Institute for Medical Research (Burnham Institute) have provided ... a suppressor role in skin cancer development. ATF2 ... the first step in the translation of genetic code, ... and ionizing radiation. This function of ATF2 in ...
... - The Vilcek Foundation has announced the names of the ... the arts. Dr. Inder Verma is the prize recipient ... composer Osvaldo Golijov. The Vilcek Foundation Prizes are awarded ... the United States. , In explaining the motivation ...
... Montefiore, NEW YORK, Feb. 6 Elephant Ensemble ... of a Brave Little,Girl to the Bronx when they ... Medical Center., This represents Elephant,s mission to bring ... hospitals who do not have significant,programming., Elephant Ensemble ...
Other Medicine News:Health News:Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine 2Health News:Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine 3Health News:Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine 4Health News:Test Detects Sensitivity to HIV Drug 2Health News:Aggressive Diabetes Therapy Lowers Death Risk, Study Finds 2Health News:Aggressive Diabetes Therapy Lowers Death Risk, Study Finds 3Health News:Gene found to play a suppressor role in skin cancer development 2Health News:Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science 2Thermogenesis Announces New Initiative to Address Veterinary Regenerative MedicineTest Detects Sensitivity to HIV DrugAggressive Diabetes Therapy Lowers Death Risk, Study FindsGene found to play a suppressor role in skin cancer developmentDr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical scienceElephant Ensemble Theater Brings New Production to Bronx Hospitals
When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator., ,Most Appropriate for the Proximal Femur, Metatarsal/Tarsal...
... its new multifunctional lithotripsy system Lithoskop. ... data management is the perfect symbiosis ... Lithoskop is an engineering masterpiece for ... applications like lithotripsy, endourology, urodiagnostics, percutaneous ...
... stimulator for the treatment of long bone ... stimulator is a useful adjunct for the ... planned or when patient compliance may be ... surgically implanted, patients are assured of therapeutic ...
... cataract surgery following refractive surgery grows larger ... for surgeons, as calculating IOL power for ... power following RK, ALK, PRK and LASIK ... or topography. For example, keratometry and simulated ...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |